<DOC>
	<DOC>NCT01630317</DOC>
	<brief_summary>Slow continuous ultrafiltration using central vs peripheral line: feasibility of implementation, safety and efficacy in acute heart failure syndromes.</brief_summary>
	<brief_title>Slow Continuous Ultrafiltration Using Central vs Peripheral Line: Feasibility of Implementation, Safety and Efficacy in Acute Heart Failure Syndromes.</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>≥ 18 years Patients hospitalized with primary diagnosis of acute heart failure defined as ≥ 2 of the following criteria: Peripheral or sacral edema Jugular venous distension or venous central pressure &gt; 10 mmHg Hepatomegaly or ascites Pulmonary edema or pleural effusion on xray or pulmonary wedge pressure or enddiastolic pressure &gt; 20 mmHg. High proBNP Randomization during first 24 hours Serum creatinine levels &lt; 3mg/dL, and K &lt; 6 mmol/L The patient should be able to communicate with research staff and meet with study procedures. The patient will signed informed consent. Diagnosis of severe aortic stenosis or severe obstruction to the LVOT, tamponade, cardiac hypertrophic or restrictive cardiomyopathy. Impossibility of venous catheterization Acute coronary syndrome Creatinine greater than 3.0 or K greater than 6 mmol/L. Systolic blood pressure less than or equal to 100 mmHg Hematocrit greater than 45% Prior administration of IV vasoactive drugs in the emergency room (ER) Clinical instability requiring pressors during hospitalization Sepsis On or requires renal dialysis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>